SCHEMBL15039584

SCHEMBL15039584

Cc1ccccc1NC1=CC(=O)C(Nc2ccc(N)cc2)=C/C1=N/c1ccc(N)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.36
▸ BLM P54132 5/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ HTT P42858 4/20 0.36
▸ APAF1 O14727 4/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ LMNA P02545 3/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ HSP90AA1 P07900 2/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ P2RX7 Q99572 1/20 0.36
▸ HPGD P15428 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ TP53 P04637 2/20 0.35
▸ APP P05067 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ SNCA P37840 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17253273 0.95 DNM1 (0.46) MAPTBLMALDH1A1HTTAPAF1
SCHEMBL15020293 0.88 DNM1 (0.51) MAPTBLMALDH1A1HTTAPAF1
SCHEMBL15039581 0.88 DNM1 (0.51) MAPTBLMALDH1A1HTTAPAF1
SCHEMBL15020291 0.88 DNM1 (0.51) MAPTBLMALDH1A1HTTAPAF1
SCHEMBL15039542 0.86 MAPT (0.46) MAPTBLMALDH1A1HTTAPAF1
SCHEMBL15039674 0.86 DNM1 (0.46) MAPTBLMALDH1A1HTTAPAF1
SCHEMBL15020149 0.86 DNM1 (0.46) MAPTBLMALDH1A1HTTAPAF1
SCHEMBL15020148 0.86 DNM1 (0.46) MAPTBLMALDH1A1HTTAPAF1
SCHEMBL15020196 0.85 MAPT (0.43) MAPTBLMALDH1A1HTTAPAF1
SCHEMBL15039805 0.85 MAPT (0.43) MAPTBLMALDH1A1HTTAPAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9554977-B2 Triaromatic azomethine direct dyes, dye composition comprising at least one such dye, method of implementation and use L'OREAL (FR) 2017-01-31 — — US disclosed
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2015-11-12 — — US disclosed
WO-2013087768-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2013-06-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE KRT18, MKI67, CDC73 MAPT 469/4885BLM 3275/4885ALDH1A1 235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback